Middle East

Angela Watkinson Excerpts

Monday 30th November 2015 Commons Chamber

[Dame Angela Watkinson (Hornchurch and Upminster) (Con)]

I intend to take a slightly different tack in not speaking, like most colleagues, about ISIL or Daesh. I want to focus my remarks on the value of our constructive relationship with Israel and the contribution that it makes to peace and stability.

The selective discrimination against Israel in UK university campuses contrasts with the huge benefits of BIRAX—the Britain Israel Research and Academic Exchange Partnership—which is an initiative of the British embassy in Israel and the British Council. Israel is a multiracial, multi-ethnic democracy where Arab, Druze and other minorities are guaranteed equal rights under law. Israel’s declaration of independence grants

“all Israel’s inhabitants equality of social and political rights irrespective of religion, race or gender”,

and it is currently the only functioning democracy in the middle east. In stark contrast to other middle eastern countries, there are no legal restrictions on movement, employment, or sexual or marital relations for any of Israel’s citizens. All Israeli citizens from every minority vote in elections on an equal basis.

In the past two months, there have been over 90 terror attacks that have seen the deaths of 21 Israelis and many more injuries from stabbings, shootings and car rammings. Yet Israeli hospitals have treated both victims and terrorists regardless of their nationality.

[Andy Slaughter (Hammersmith) (Lab)]

If the hon. Lady is going to quote statistics, she should perhaps do so completely. Since the beginning of October, the violence on the west bank has resulted in 85 Palestinian deaths and 11 Israeli deaths, and 9,171 Palestinian injuries and 133 Israeli injuries. That is a ratio of 69:1.

[Dame Angela Watkinson]

The hon. Gentleman is quoting from his speech, and I will come to those matters as I continue with mine.

In addition, Israel has participated in disaster relief efforts worldwide, most recently providing assistance to Syrian refugees arriving in Greece and elsewhere.

Violence has been fomented by repeated inflammatory and false allegations from the Palestinian Authority, Fatah and Hamas accusing Israel of planning to destroy the al-Aqsa mosque and other Muslim holy sites in Jerusalem. Yet Hadassah medical centre, home to Jerusalem’s largest emergency ward, treats the city’s wounded regardless of whether they are victims or attackers, and co-operation between Palestinian and Israeli doctors has helped to save 607 Palestinian children since 2005. The hospital has mixed Jewish and Arab medical staff and routinely treats both attackers and victims, often in adjacent wards.

[John Howell (Henley) (Con)]

I wonder whether my hon. Friend, like me, has been to Save a Child’s Heart in Tel Aviv and acknowledges that the work that the doctors there do in the Palestinian territories, particularly in Gaza, is second to none in saving children’s lives.

[Dame Angela Watkinson]

My hon. Friend is absolutely right. When I continue my remarks, he will find that I cover that.

Israel’s Teva Pharmaceutical Industries provides the NHS with one in six of its prescription medicines, making it the NHS’s largest supplier of generic drugs. It is leading the world in the development of drugs to combat Alzheimer’s disease, cancer, Parkinson’s disease, and multiple sclerosis. Scientists have developed methods for producing human growth hormone and interferon, a group of proteins effective against viral infections. Copaxone, a medicine effective in the treatment of multiple sclerosis, was developed in Israel by Teva Pharmaceuticals from basic research to industrial production. It has also developed early diagnosis for mad cow disease and Creutzfeldt-Jakob genetic disease in humans, with a urine test instead of a brain biopsy, and identified the gene that causes muscular dystrophy and the gene linked to post-traumatic stress disorder.

In July 2015 the British embassy announced three new water research programmes between UK and Israeli scientists. The work of Israeli research institutions, such as Tel Aviv University and the Weizmann Institute of Science, improves the lives of people in water-poor countries by sharing Israel’s expertise in waste water treatment, purification and water reuse. The programmes will enable scientists from Britain, Israel and the region to work together to tackle water shortages.

Israel is one of the founding members of Digital 5, a group of leading digital Governments who met for the first time in London in December 2014. In March 2015 it was announced that three UK-Israel academic collaboration projects will receive £1.2 million of cyber-research funding from the UK Government.

The total value of trade and services between the UK and Israel is now more than £4.5 billion a year, and the UK is Israel’s second biggest export market. British businesses such as HSBC, GlaxoSmithKline, Barclays and Rolls-Royce have invested more than £1 billion in Israel. The UK and Israel work closely together in technological and scientific research, including cyber-security.

In short, Israel is a tolerant, fair society. Creative and innovative, it produces and develops, and it advances knowledge. Britain’s close relationship with Israel is a force for good in the middle east, and it is essential that we build and maintain that strong relationship.